FDA clears first blood test for Alzheimer’s detection

The Food and Drug Administration has cleared Fujirebio Diagnostics’ blood test to diagnose Alzheimer’s disease, the regulator said today, making the device the first of its kind to detect the brain-wasting condition.

See the original article at: Honolulu Star-Advertiser